Advertisement

Letter to the Editor

  • 4 Citations

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 189

This is the net price. Taxes to be calculated in checkout.

References

  1. 1.

    Bloomfeld D, Kost J, Ghosh K, et al. The effect of moxifoxacin on QTc and implications for the design of thorough QT studies. Clin Pharmacol Ther. 2008;84:475–480.

  2. 2.

    Florian JA, Tornoe C, Brundage R, Parekh A, Gar-nett C. Population pharmacokinetic and concen-tration-QTc models for moxifoxacin: pooled analysis of 20 thorough QT studies. J Clin Pharmacol. 2011;51:1152–1162.

  3. 3.

    Yan LK, Zhang J, Ng MJ, Dang Q. Statistical characteristics of moxifoxacin-induced QTc effect. J Biopharm Stat. 2010;20:497–507

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Zhang, J., Stockbridge, N. Letter to the Editor. Ther Innov Regul Sci 45, 713–715 (2011) doi:10.1177/009286151104500506

Download citation